What Medtech CEOs Expect from the Second Half of the Year

Since the beginning of the year, it seems, all eyes have been on the second half of 2021 as medtech companies were still grappling with a lot of uncertainty heading into 2021. Now that we're well into the second quarter, here are some key takeaways from first-quarter earnings calls from a handful of medtech companies that were most impacted by COVID-19 disruptions and lower procedure volumes.